Allurion Technologies (ALURD) Long-Term Deferred Tax (2022 - 2023)
Allurion Technologies' (ALURD) quarterly Long-Term Deferred Tax came in at $1.6 million in Q4 2023, up 106.57% YoY from $792000.0 in Q4 2022, and up 106.57% on a QoQ basis from $792000.0 in Q4 2022.
Allurion Technologies (ALURD) Long-Term Deferred Tax (2022 - 2023) Analysis & Trends
Allurion Technologies (ALURD) has 2 years of Long-Term Deferred Tax data on file, last reported at $1.6 million in Q4 2023.
- Quarterly Long-Term Deferred Tax rose 106.57% year-over-year to $1.6 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.6 million (up 106.57% YoY) and the FY2023 annual result came in at $1.6 million, up 106.57% from the prior year.
- Long-Term Deferred Tax advanced to $1.6 million in Q4 2023, from $792000.0 in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $1.6 million in Q4 2023 to a low of $792000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.64 Mn |
| Dec 31, 2022 | 792,000.00 |